Gene Query: HIST2H3A

Dataset Description Geneva Score
Uridylation by TUT4 and TUT7 marks mRNA for degradation 136.62
RUNX1 contributes to higher-order chromatin organization and gene regulation in breast cancer cells. 113.69
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription [RNA-Seq] 104.0
Genome-wide MAF1-dependent regulation of RNA polymerase III transcription 104.0
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia 97.57
ncRNA (non-coding RNA) signature in endothelial cells during hypoxia [RNA-seq] 97.57
ARID1A and PI3-Kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion 95.11
Studying the selectivity of a small molecule Synucleozid on transcriptome 94.67
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 93.37
Impact of dieldrin on transcription in Jurkat T cells 92.31
Targeted inhibition of STAT/TET1 axis as a potent therapeutic strategy for acute myeloid leukemia 92.19
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 91.89
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes. 79.49
Integrator complex regulates NELF-mediated RNA Polymerase II pause/release and processivity at coding genes [RNA-seq] 79.49
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray [RNA-Seq] 78.31
Circular RNAs are super abundant in cervical tumor and plasma detected by high throughput microarray 78.31
Efficient and quantitative high-throughput tRNA sequencing 77.63
Gene target specificity of the Super Elongation Complex (SEC) family: How HIV-1 Tat employs selected SEC members to activate viral transcription 72.44
Gene expression changes caused by KRAS in MCF-10A 71.55
Ribosome profiling of A549 cells depleted of RPLP1 and RPLP2 and infected with DENV. 67.56
Zika infected neural stem cells 67.31
Transcriptome analysis of Zika infected neural stem cells 67.31
Characterizing the contrasting roles of JMJD3 and UTX histone demethylases in T cell acute lymphoblastic leukemia [short_hairpins_RNA-seq] 65.41
High-throughput RNA sequencing on circular RNA profiles of human triple-negative breast cancer and adjacent normal tissues 64.9
MYCi361 regulates MYC target genes 64.39
Human TFIIH kinase CDK7 regulates transcription-associated epigenetic modification 64.38
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 63.9
LMO1 Synergizes with MYCN to Promotes Neuroblastoma Initiation and Metastasis 62.7
STVI-120 Induction of differentiation in human epidermal stem cells followed by differential splicing analysis 59.05
Single-nucleotide-resolution mapping of HBV promoters using CAGE 58.43
Next generation sequencing identifies discrete classes of box C/D snoRNAs featuring different ends and RNA binding protein dependency 57.82
Tracking distinct RNA populations using efficient and reversible covalent chemistry 56.53
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 56.32
Effect of BCL11B overexpression on transcriptome of T-cell acute lymphoblastic leukemia (T-ALL) cells 55.64
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 51.55
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 50.25
Expression and functions of long noncoding RNAs during human T helper cell differentiation 49.53
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 48.74
A radiolabeling-free, qPCR-based method for locus-specific pseudouridine detection 48.25
Total RNA deep sequencing (ribosomal depleted) of human umbilical vein endothelial cells exposed to hypoxia (0.2%) for 12h and 24h or kept under normoxic conditions. 47.51
Endothelial gene expression analysis 47.51
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells with PolyIC treatment 47.16
Glioma Stem Cell Specific Super Enhancer Drives Polyunsaturated Fatty Acid Synthesis to Support EGFR Signaling 46.02
Circular RNAs in the mammalian brain are highly abundant, conserved, and dynamically expressed 45.39
Genome-wide view of the impact of Spt5-Pol II inhibitors (SPIs) on mRNA levels [RNA-Seq 24h] 44.06
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 43.93
Selective roles of vertebrate PCF11 in premature and full-length transcript termination (chromatin-bound RNA-seq) 42.61
RNA-seq of resting and activated CD4+ T cells +-JQ1 42.52
Transcriptome profiling of hnRNP A2/B1 and A1 depleted cells 39.7
Global response to chemotherapy-induced apoptosis 39.69
Transcriptome sequencing wide functional analysis of human mesenchymal stem cells (Poly(I:C) and LPS) 39.26
High-throughput RNA sequencing on circular RNA profiles of human bladder cancer tissues and normal bladder tissues 38.79
Transcriptome of iPSC-derived Neural Cells with Heterozygous Knockout in CHD8 38.64
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 38.6
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 38.4
Landscape of H3K4me3 in human CD19 cells 37.93
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 37.69
Differential roles of human PUS10 in miRNA processing and tRNA pseudouridylation 37.65
Regulation of PRMT5-MDM4 axis is critical in the response to CDK4/6 inhibitors in melanoma 37.4
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 37.0
Transcriptomic profiling of HeLa cells infected with Salmonella Typhimurium 36.91
Two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 36.7
Gene expression profiling in two dimensional and extracellular matrix based three-dimensional cultures of lung and breast cancer cells 36.7
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 36.43
Gene expression by high-throughput sequencing of T47D-MTVL human breast cancer cells upon H1.4 knock-down and multiple H1 variants 35.17
Comprehensive comparative analysis of 5’ end RNA sequencing methods 34.68
Gene induction by the USP6 oncogene in response to interferon 33.98
MPTAC determines APP fragmentation via sensing sulfur amino acid catabolism 33.94
A quantitative chemotherapy genetic interaction map identifies new factors associated with PARP inhibitor resistance 33.63
Genes significantly down or Up-regulated upon RNF219 knockdown 33.5
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 33.34
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and PVT1 Knockdown by CRISPRi in MDA-MB-231 human breast cancer cell line 33.31
Promoter of lncRNA gene *PVT1* is a tumor suppressor DNA element 33.31
E2F1 orchestrates transcriptomics and oxidative metabolism in Wharton’s jelly derived mesenchymal stem cells from growth-restricted neonates 33.28
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 32.82
HDAC inhibition enhances the in vivo efficacy of MEK inhibitor therapy in uveal melanoma 32.71
U1 snRNP telescripting regulates size-function stratified human genome 32.54
hMTR4 plays a central role in creating balanced nuclear RNA pools for degradation and export 32.24
RNASeq of 4SU labelled nascent RNA in MV4;11 cell treated with DMSO, I-BET, SGC0946 and combination of I-BET and SGC0946 31.99
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 31.96
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 31.02
Role of microRNAs in the interaction between Salmonella and the host cell 30.82
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 30.78
Transcriptome profiling identified a 3-lncRNA regulatory network in transthyretin against glucose induced hRECs dysfunction 30.77
The metabolome regulates the epigenetic landscape during naïve to primed human embryonic stem cell transition 30.76
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 30.73
TT-Seq captures the human transient transcriptome 30.65
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development [RNA-Seq] 30.06
Transcriptomic analysis reveals novel long non-coding RNAs critical for vertebrate development 30.06
circ-ZNF609 regulates G1-S progression in Rhabdomyosarcoma 29.51
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 28.72
Role for citron kinase in prostate cancer growth 28.13
Differentially expressed genes from RNA-Seq and functional enrichment results are affected by the choice of single-end versus paired-end reads and stranded versus non-stranded protocols 28.07
Effect of BB608 on Gene Expression in HNSCC Cell Line 27.9
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) of BJ cells treated with Nutlin-3a, an MDM2 inhibitor, which induces p53. 27.5
Identification of HOXB13 target genes responsive to BET inhibitors 26.74
Widespread Transcription beyond mRNA 3’ Ends Yields Abundant Regulatory RNAs 26.18
JQ1 +/- Vemurafenib in BRAF mutant melanoma (A375) 26.03
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction 25.95
RUNX1-ETO and RUNX1-EVI-1 differentially program the chromatin landscape in t(3;21) and t(8;21) AML but share global C/EBP-alpha dysfunction (RNA-Seq) 25.95
Modulation of ESRP2 and MBNL2 in normal kidney and clear cell renal cell carcinoma cell lines for analysis of stability programs 25.85
The effect of REST and its alternatively spliced transcript, REST-003, on breast cancer invasiveness 25.68
NRDE2 negatively regulates nuclear exosome functions 25.47
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 25.06
Mapping interactions for the TNIP2 hub protein 24.78
The Molecular Dissection of the Oncogenic Role of ETS1 in the Mesenchymal Subtypes of Head and Neck Squamous Cell Carcinoma [RNA-seq knock-down] 24.24
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 23.51
Genome models integrating chromatin contacts and nuclear lamin-genome interactions reveal implications of laminopathy-causing lamin mutations on genome architecture 23.21
Human embryonic stem cell, chimpanzee induced pluripotent stem cell, orangutan induced pluripotent stem cell, rhesus embryonic stem cell, and their derived cortical organoid RNA-seq 22.77
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator 22.66
ZBTB48 is both a vertebrate telomere-binding protein and a transcriptional activator [RNA-seq] 22.66
Cooperation of Nutlin-3a and a Wip1 inhibitor to induce p53 activity 22.5
NET-CAGE Characterizes the Dynamics and Topology of Human Transcribed Cis-regulatory Elements 22.26
Long non-coding RNA SMILR regulates genes involved in cytokinesis in human vascular smooth muscle cell 22.23
Integrative transcriptome-wide analyses reveal critical HER2-regulated mRNAs and lincRNAs in HER2+ breast cancer 22.2
Ribo_seq (aka ribosome profiling) analysis of control and Myc-induced U2OS cells 22.2
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation [RNA-Seq] 22.11
Bromodomain protein BRD4 is required for estrogen receptor-dependent transcription and enhancer activation 22.11
DRB/GRO-Seq -/+ UV 22.09
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer [RNA-seq] 22.09
A non-canonical role of YAP/TEAD is required for activation of estrogen-regulated enhancers in breast cancer 22.09
Human co-transcriptional splicing kinetics and coordination revealed by direct nascent RNA sequencing 22.09
Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B 21.94
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 21.91
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 21.61
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 21.61
RNA-sequencing transcriptome profiling of normal human keratinocytes differentiation 21.57
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 21.52
EWS-Fli and LNC regulated genes in comparison to GFP samples 21.36
Retinoic acid suppresses MYB in adenoid cystic carcinoma 21.29
Retinoic acid suppresses MYB in adenoid cystic carcinoma [RNA-seq] 21.29
RNA-sequencing of isogenic primary, pre-malignant immortalized, and Ras-transformed human mammary epithelial cells 20.81
Transcriptomic analysis of healthy donor and Sickle Cell Disease (SCD) hematopoietic stem/progenitor cells 20.53
An RNA-centric dissection of host complexes controlling flavivirus infection [RNA-Seq] 20.5
An RNA-centric dissection of host complexes controlling flavivirus infection 20.5
Selectively targeting bromodomain and extraterminal proteins for degradation as a novel anti-glioblastoma strategy [RNA-seq] 20.38
p63 controls the enhancer landscape during keratinocyte differentiation 20.33
shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 reveals set of genes potentially coregulated by MED25 and ETV4 20.26
Genome-wide occupancy of FLAG-MED25 and ETV4 and expression profiling of shRNA-mediated knockdown of ETV4 and MED25 in the prostate cell line PC3 20.26
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues (sequencing) 20.13
mRNA destabilization is the dominant effect of mammalian microRNAs by the time substantial repression ensues 20.13
Cellular gene expression during Hepatitis C Virus replication revealed by Ribosome profiling 19.78
High-throughput RNA sequencing on circular RNA profiles of human pancreatic cancer cell lines and gemcitabine resistant pancreatic cancer cell lines. 19.69
High-throughput sequencing of pluripotent cells 19.52
RNA-dependent RNA polymerase sequence specificities of capsnatching viruses are tailored to aid viral replication 19.25
BAF controls genome accessibility 19.22
RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 19.11
RNA-seq Profiles in RBPJ Maintains Brain Tumor Initiating Cells through CDK9-mediated Transcriptional Elongation 19.11
Inducible three-factor direct reprogramming to nephron progenitors using piggyBac transposons 19.06
A code of mono-phosphorylation modulates the function of RB. 19.05
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 18.98
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 18.98
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 18.84
circRNA profile in hypopharyngeal cancer 18.83
RNA-sequencing of formalin fixed human primary melanoma tissue 18.78
Human iPSC derived glomeruli facilitate accurate modelling of podocytopathy 18.44
RNA Sequencing of three pairs of gastric cancer 18.41
LncPRESS1 is a p53-regulated lncRNA that safeguards pluripotency by disrupting SIRT6 mediated de-acetylation of histone H3K56 18.26
RNA sequencing for lncRNA, miRNA and mRNA expression analysis in human laryngeal cancer 18.13
Mutation independent activation of the Notch pathway is associated with Lapatinib resistance in Her2+ breast cancer cell lines 17.99
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 17.83
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 17.83
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 (RNA-Seq) 17.8
Activation of PARP-1 by snoRNAs Controls Ribosome Biogenesis and Cell Growth via the RNA Helicase DDX21 17.8
Short and long-term effects of CDK4/6 inhibition on early stage breast cancer 17.68
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 17.63
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreas cancer 17.61
Generation of induced neural stem cells from urine derived cells by synthetic mRNA 17.54
Epigenetic Lanscape and BRD4 Transcriptional Dependency of PAX3-FOXO1 Driven Rhabdomyosarcoma 17.29
PAX3-FOXO1 requires BRD4 to drive oncogene addiction in RMS cells [RNA-seq] 17.29
Transcriptomic but not genomic variability confers phenotype of breast cancer stem cells 17.21
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq SS] 17.05
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells 16.91
Genome-wide DNA accessibility maps and differential gene expression using ChIP-seq, ATAC-seq and RNA-seq for the human secondary fibroblast cell line hiF-T and whole worms with and without knockdown of FACT complex 16.86
HEK293 Heat-shock experiment 16.72
High-Throughput Screening of Human Induced Pluripotent Stem Cell Cardiomyocytes Predicts Tyrosine Kinase Inhibitor Cardiotoxicity 16.66
Tyrosine Kinase Inhibitor Cardiotoxicity 16.66
RNA-Seq with and without RNase treatment in PCa cell lines 16.45
Reassessment of Exosome Composition 16.15
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs [GRO-seq II] 16.0
The ribonuclease activity of SAMHD1 is required for HIV-1 restriction 16.0
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation [human cell line RNA-seq] 15.88
A zebrafish melanoma model reveals emergence of neural crest identity during melanoma initiation 15.88
Splicing and epigenetic factors jointly regulate epidermal differentiation 15.79
Genome-wide identification of cancer-specific alternative splicing in circRNA 15.77
Metabolic reprogramming of Kaposi’s sarcoma associated herpes virus infected B-cells in hypoxia 15.76
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 15.67
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 15.67
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 15.67
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 15.67
RNA-sequencing in irradiated and normal A549 cells. 15.41
circRNA-sequencing 15.38
RNA-seq of YB5 cells treated with Proscillaridin A 15.32
mTORC1 balances cellular amino acid supply with demand for protein synthesis through post-transcriptional control of ATF4 15.03
Genome-wide maps of WT and over-expressing CenH3/CENP-A in Human HeLa S3 cells 14.92
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated Glia [shRNA] 14.82
Dynamic 3D chromosomal landscapes in acute leukemia 14.81
Dynamic 3D chromosomal landscapes in acute leukemia [RNA-Seq] 14.81
Short and Long RNA sequencing of human mature erythrocytes 14.72
A role for ZNF598 in post-transcriptional gene regulation 14.71
Solid phase chemistry to covalently and reversibly capture thiolated RNA 14.67
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 14.55
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 14.43
Recapitulation of Human Neural Microenvironment Signatures in iPSC-Derived NPC 3D Differentiation 14.3
Genome-wide search for differentially expressed RNAs responsible for the effects induced by Ebola virus replication and transcription 14.17
BRG1 governs Glucocorticoid Receptor interactions with chromatin and pioneer factors across the genome 14.1
Differential Gene Expression between MCF10A and MCF7 cells 13.84
Differential responses of human fetal brain neural stem cells to Zika virus infection 13.78
Selective expression of long non-coding RNAs in a breast cancer cell progression model 13.78
SnapShot-Seq: a method for extracting genome-wide, in vivo mRNA dynamics from a single total RNA sample 13.75
RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer 13.65
RNA polymerase in pre-B-ALL cell lines 13.54
Base-resolution mapping reveals distinct classes of N1-methyladenosine methylome in nuclear- and mitochondrial-encoded transcripts 13.53
Three congruent human Schwann cell models of CMT1A reveal a converged phenotype 13.52
R430: A potent inbibitor of DNA and RNA viruses 13.37
Next Generation Sequencing Facilitated Differential Transcriptome Study of melanoma cells transduced with Notch 1 Intracellular Domain (NICD) 13.36
Differentiation enhances Zika virus infection in neuronal brain cells 13.29
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 12.6
C9orf72 Intermediate Repeats are Associated with Corticobasal Degeneration, Increased C9orf72 Expression and Disruption of Autophagy 12.6
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 12.56
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 12.36
LINC00520 is Induced by Src, STAT3, and PI3K and Plays a Functional Role in Breast Cancer 12.28
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 12.12
BCL11B 11.79
Profiling and bioinformatics analyses reveal differential expression of circular RNA in tongue cancer revealed by high-throughput sequencing 11.73
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 11.66
Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells 11.64
DHX9 suppresses spurious RNA processing defects originating from the Alu invasion of the human genome [uvCLAP CLIP-seq] 11.58
BI Human Reference Epigenome Mapping Project 11.58
Comparison of microRNA Profiling Platforms (HTS) 11.53
Comparison of microRNA Profiling Platforms 11.53
miR-191 regulates human cell proliferation and directly targets multiple oncogenes [seq] 11.52
Genome wide miR-191 target profile determined by RIP and gene expression profiling 11.52
Effect of circPTPRM on the biological behaviors of hepatocellular carcinoma cells in vitro and its clinical significance. 11.5
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 11.46
Epigenome regulation during epidermal lineage commitment [ATAC-seq, RNA-seq] 11.38
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 11.38
The effects of U1 snRNA mutation in chronic lymphocytic leukemia cell lines 11.2
Landscape and variation of RNA secondary structure across the human transcriptome 11.13
Cooperation of GRSF1 and the mitochondrial degradosome (hSuv3-PNPase complex) in degradation of mitochondrial RNA 11.13
Transcriptional dependencies in diffuse intrinsic pontine glioma 11.08
Comparative transcriptomic analysis of human and Drosophila extracellular vesicles reveals extensive conservation 10.95
TUT-DIS3L2 is a mammalian surveillance pathway for aberrant structured non-coding RNAs. 10.91
Uridylation-mediated RNA quality control pathway in mammalian cytoplasm [RNA-Seq] 10.91
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network with PRC2 [RNA-seq] 10.61
MicroRNAs reinforce repression of PRC2 transcriptional targets independently and through a feed-forward regulatory network 10.61
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 10.56
The pause-initiation limit restricts transcription activation in human cells 10.46
Presence of NAD+-capped RNA in human cells: function and removal by the DXO deNADing Protein 10.4
Genome-wide maps of m6A circRNAs identify widespread and cell-type-specific methylation patterns that are distinct from mRNAs 10.34
Oncogenic MYC induces a dependency on the spliceosome in human cancer 10.31
Laminin-guided highly efficient endothelial commitment from human pluripotent stem cells [Bulk RNA-Seq] 10.31
10.21
Insights into snoRNA biogenesis and processing from PAR-CLIP of snoRNA core proteins and small RNA sequencing 10.2
Expanding the Nucleoside Recoding Toolkit: Revealing RNA Population Dynamics with 6-thioguanisine 10.08
The RNA helicase DDX6 regulates self-renewal and differentiation of human and mouse stem cells [RNA-seq] 10.03
Uridilation by TUT4/7 restricts retrotransposition of human Line-1s 10.03
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 10.01
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 9.97
Evolving Spindlin1 Small Molecule Inhibitors Using Protein Microarrays 9.94
Mitochondrial dsRNA triggers antiviral signalling in humans 9.9
Global Transcriptional analysis of human spinal cord and neocortical neuroepithelial stem (NES) cells 9.84
The NFkB subunit RELA is a master transcriptional regulator of the committed epithelial-mesenchymal transition in airway epithelial cells 9.68
MYCi975 regulates MYC target genes 9.65
RNA-Seq profiling of day 7 and day 18 kidney organoids differentiated in two batches 9.59
Gene expression profiling of human and murine in vitro muscle differentiation 9.5
The long non-coding RNA MALAT1 contributes to the pathogenesis of multiple sclerosis through alternative splicing and backsplicing regulation 9.43
Epigenome-wide analysis of DNA methylation in lung tissue shows concordance with blood studies and identifies tobacco smoke-inducible enhancers 9.38
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) 9.37
Global analysis of pre-mRNA subcellular localization upon splicing inhibition by spliceostatin A 9.37
The WNT target SP5 negatively regulates WNT transcriptional programs in human pluripotent stem cells 9.33
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 9.24
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 9.22
Analyzing the interactions of mRNAs, miRNAs, lncRNAs and circRNAs to predict competing endogenous RNA networks in glioblastoma 9.0
Identification of transcription start sites for human A549 cell line using ReCappable-seq 8.92
UMI-count modeling and differential expression analysis for single-cell RNA sequencing 8.9
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 8.87
Genes regulated by soluble guanylyl cyclase in VCaP prostate cancer cells 8.86
Determination of tRNA aminoacylation levels by high throughput sequencing 8.85
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease 8.81
REST and Neural Gene Network Dysregulation in iPS Cell Models of Alzheimer’s Disease (RNA-seq data set) 8.81
Retroviral Replicating Vectors Deliver Cytosine Deaminase Leading to Targeted 5-FU-Mediated Cytotoxicity in Multiple Human Cancer Types 8.8
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 8.7
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 8.69
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 8.69
A systematic analysis of the time series gene expression in TGF-beta induced EMT by Next-generation sequencing 8.69
RNA editing in nascent RNA affects pre-mRNA splicing 8.66
Enhancer activation during EGF response 8.65
RNA-Seq analysis of cSCC cells after siRNA-induced gene knockdown of lncRNA PRECSIT 8.64
Comparative total RNA and mRNA sequencing and systems analysis reveals nascent transcriptional response to early HIV-1 infection in a CD4+ T cell line 8.63
Proteinase-Activated Receptor 4 (PAR4) mediates cell membrane blebbing in a Gaq/11, Gai independent, RhoA and ß-arrestin-dependent manner. 8.49
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation [RNA-Seq rescue_SS] 8.47
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 8.42
Specific labeling of stem cell activity in human colorectal organoids using an ASCL2-responsive minigene 8.4
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 8.4
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 8.4
Epigenome regulation during epidermal lineage commitment 8.35
Expression profile of wild type (WT) vs miR-155-/- in FLT3-ITD+ AML (MV4-11) cell lines 8.3
Genome-wide CRISPR-Cas9 screen identifies functionally relevant microRNAs in AML 8.3
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 8.26
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 8.19
Ribosomal footprinting of CN34-Parental and CN34-LM1a 8.13
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 8.05
ChIPseq and RNAseq analysis of T47D cells with/without silencing TRPS1/CHD4 8.05
The interplay between SOX4 and SMAD3 in the context of breast cancer 7.96
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 7.96
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 7.94
Human cells contain natural double-stranded RNAs with potential regulatory capacity 7.91
Transcription elongation regulates genome 3D structure 7.82
Programmable RNA N6-methyladenosine editing by CRISPR-Cas9 conjugates 7.76
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 7.69
Overexpression of PHF8 promotes an EMT-related gene signature in MCF10A cells 7.66
Genome-wide analysis of the Integrator complex (HTS) 7.64
Genome-wide analysis of the Integrator complex 7.64
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 7.64
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 7.55
Medial Ganglionic Eminence and Cortical Organoids Model Human Brain Development and Interneuron Migration 7.54
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 7.54
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 7.54
Epigenome regulation during epidermal lineage commitment [RNA-seq] 7.52
m6A-dependent regulation of messenger RNA stability 7.4
RNA deep sequencing analysis of glioma stem cells(GSCs) and non-GSCs 7.38
Transcriptomic profile of T cell acute lymphoblastic leukemia (T-ALL) cell from patients in CHCQMU 7.38
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 7.33
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 7.32
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells 7.27
Toxoplasma gondii remodels the cis-regulatory landscape of infected human host cells [RNA-seq] 7.27
RNA expression analysis of neuroblastoma cell lines treated with epigenetic drugs 7.16
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 7.15
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 7.12
Gene expression profile of human iPSC-derived nephron progenitor cells 7.09
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 7.05
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 7.04
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation 6.89
Androgen receptor functions as transcriptional repressor of Cancer Associated Fibroblast (CAF) activation [RNA-seq] 6.89
In vivo generation of post-infarct human cardiac muscle by laminin-promoted cardiovascular progenitors [LN-521 or LN-521+LN-221] 6.86
Genome-scale identification of transcription factors that mediate an inflammatory network during breast cellular transformation 6.77
RNA-seq during MCF10A-ER-Src cell transformation and upon factor knockdowns 6.77
Methylation DNA mediated KLF4 binding activity in glioblastoma cells 6.72
LncRNA-dependent mechanisms of androgen receptor-regulated gene activation programs 6.7
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 6.6
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 6.58
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 6.58
Genome-wide RNA-sequencing (RNA-seq) of benign and malignant prostate cell lines without and with androgen (R1881) stimulation. 6.49
RB tumor suppressor promotes cancer immunity through downregulating PD-L1 expression 6.44
Hyper-activation of HUSH complex function by Charcot-Marie-Tooth disease mutation in MORC2 6.39
Subcellular RNA fractions of HSV-1 infected primary human fibroblasts 6.38
Global transcriptional changes in the JJN3 myeloma cell line that occur as a result of treatment with 2 pyrrolobenzodiazepine (PBD) monomers 6.36
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 6.32
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 6.32
6mer seed toxicity in tumour suppressive microRNAs 6.2
Conservative alteration of chromosomal expression pattern across human solid tumor types 6.15
Genome-wide discovery of human splicing branchpoints 6.11
RNA-seq in LNCaP cell line overexpressing WT or mutant FOXA1 5.96
Forkhead domain mutations in FOXA1 drive prostate cancer cell progression 5.96
The expression profiles of GBC liver metastasis 5.93
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 5.86
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 5.85
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 5.85
A Druggable TCF4- and BRD4-dependent Transcriptional Network Sustains Malignancy in Blastic Plasmacytoid Dendritic Cell Neoplasm (RNA-Seq) 5.69
MLL-AF4 Spreading Identifies Binding Sites that Are Distinct from Super-Enhancers and that Govern Sensitivity to DOT1L Inhibition in Leukemia. 5.57
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability 5.53
Elongation Factor TFIIS Prevents Transcription Stress and R-Loop Accumulation to Maintain Genome Stability [ RNA-seq] 5.53
Global transcriptome analysis of WT versus HEB-/- hESCs 5.39
p53 activity results in DNA replication fork processivity 5.28
RNA-seq of SCLC PDX models treated with EP 5.23
Precise Gene Editing Preserves Hematopoietic Stem Cell Function Following Transient p53-Mediate DNA Damage Response [bulk RNA-seq] 5.1
circNFIB suppresses lymphatic metastasis of pancreatic cancer 5.09
RNA-seq of cells with TET1 knockout 5.07
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 5.03
ARID1A regulates condensin II distribution and chromosomal partition 4.99
ARID1A regulates condensin II distribution and chromosomal partition [RNA-seq] 4.99
RNA transcriptome analysis during HSV-1 infection 4.92
Regulation of poly(A) tail and translation during the somatic cell cycle 4.72
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 4.65
SRSF1 role in cellular gene expression and splicing 4.62
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.59
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.59
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 4.57
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 4.55
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 4.48
Wide-spread disruption of transcription termination in HSV-1 infection: Next-generation sequencing of translational activityd by ribosome profiling 4.44
Transcriptome-wide analysis of the role of HTLV-1 Tax PBM in T-Cells from infected humanized-mice (hu-Mice) 4.36
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells 4.35
Histone variant H2A.Bbd is associated with active transcription and mRNA processing in human cells [RNA-Seq] 4.35
Genome-wide profiling of cervical RNA-binding proteins identified HPV regulation of RNASEH2A expression by viral E7 and E2F1 4.22
Transcriptome landscape of HeLa response upon triamcinolone acetonide 4.09
A cytoplasmic COMPASS is necessary for cell survival and triple-negative breast cancer pathogenesis by regulating metabolism 4.01
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 3.93
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 3.89
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 3.89
Estrogen Receptor Beta Impacts Hormone-Induced Alternative mRNA Splicing in Breast Cancer Cells 3.8
UBE3A-mediated regulation of imprinted genes and epigenome-wide marks in human neurons 3.73
Interphase condensins regulate ligand-depedent enhancer activation 3.71
Interphase condensins regulate ligand-depedent enhancer activation (GRO-seq) 3.71
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex (Gro-seq) 3.51
Enhancer Activation Requires Trans-Recruitment of a Mega Transcription Factor Complex 3.51
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency 3.49
Critical role of transient activation of human endogenous retroviruses during reprogramming toward pluripotency (RNA-Seq) 3.49
An siRNA screen identifies CHD4 as a target for epigenetic therapy 3.49
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG [RNA-seq] 3.38
Re-programing chromatin with a bifunctional LSD1/HDAC inhibitor induces therapeutic differentiation in DIPG 3.38
UV_24h_GRO-Seq 3.36
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 3.35
TAF1 is critical for AE driven leukemogenesis 3.35
Derivation of kidney organoids from human pluripotent stem cells [RNA-Seq: Data Set 1] 3.18
RNA sequencing of lesional and nonlesional skin from patients with atopic dermatitis 3.14
The RNA exosome nuclease complex regulates human embryonic stem cell differentiation 3.11
Zika virus infection reprograms global transcription of host cells to allow sustained infection 3.1
Newly defined ABCB5+ dermal mesenchymal stem cells promote healing of chronic iron overload wounds via secretion of interleukin-1 receptor antagonist 3.08
Characterisation of the EZH2 regulated transcriptome in de novo transformed cells (RNA-Seq) 3.04
4sUDRB-seq: measuring transcription elongation and initiation genomewide 3.04
Transcriptomic Alterations in Lung Adenocarcinoma Unveil New Mechanisms Targeted by the TBX2 Subfamily of Tumor Suppressor Genes 3.02
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 2.99
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 2.99
Entrectinib Resistance in a Neuroblastoma Xenograft Model 2.97
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 2.92
Studying the selectivity of a targeted small molecule degrading a hypoxia-associated non-coding RNA 2.92
iPSCs Reveal Protective Modifiers of the BMPR2 mutation in Pulmonary Arterial Hypertension 2.81
Dynamic reorganization of nuclear architecture during human cardiogenesis [RNA-seq] 2.76
Dynamic reorganization of nuclear architecture during human cardiogenesis 2.76
Transcriptome of melanoma cell lines resistant to inhibition of the MAPK pathway. 2.71
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.64
Circular RNA profiling reveals the different distribution/characteristic and possible transport mechanism among the subcellular fractions 2.6
Transcriptome-analysis of patient-derived normal and ulcerative colitis intestinal epithelial organoids 2.53
Positively selected enhancer elements endow tumor cells with metastatic competence 2.52
Long non-coding RNA TYKRIL controls pericyte function and survival in the cardiovascular and central nervous system through regulation of p53 activity and PDGFRß expression 2.47
Effects of plasticizers (bisphenol A, bisphenol AF) and an herbicide in MCF7 human breast cancer cells 2.41
Montelukast counteracts the influenza virus-induced block in unfolded protein stress response and reduces virus multiplication 2.39
CD8+ T cells regulate tumor ferroptosis during cancer immunotherapy 2.32
Functional Significance of U2AF1 S34F Mutation in Lung Adenocarcinomas 2.29
Genome-wide modelling of transcription kinetics reveals patterns of RNA processing delays 2.27
Targeting EZH2 in MYCN-amplified Neuroblastoma [RNA-seq] 2.24
Comprehensive comparative analysis of RNA sequencing methods for degraded or low input samples 2.23
Role for the Transcriptional Activator ZRF1 in Breast Cancer Progression and Endocrine Resistance 2.22
RNAseq analysis of ruxolitinib treated breast cancers 2.1
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.97
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 1.8
Microprocessor mediates transcription termination in long noncoding microRNA genes 1.8
hsa-miR-503, hsa-miR-103, and hsa-miR-494 genome wide target profiles [RNA-Seq and RIP-Seq] 1.8
Genome-wide hsa-miR-503, hsa-miR-103, and hsa-miR-494 target profiles 1.8
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 1.77
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 1.77
RNA-seq of MDA-MB-231 cells with TET1 knockout 1.74
Mutant p63 disrupts the key specification switch from the multipotent cell state to stratified epithelia during epithelial differentiation/in ectodermal dysplasia disorders 1.74
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 1.73
SNHG12 knockdown in Human Umbilical Vein Cells under ROS conditions. 1.72
Analysis of human ES cell differentiation establishes that the dominant isoforms of the lncRNAs RMST and FIRRE are circular 1.7
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 1.55
System-wide profiling of RNA-binding proteins uncovers key regulators of virus infection 1.48
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma [RNA-seq] 1.36
Targetting super enhancer associated oncogenes in esophageal squamous cell carcinoma 1.36
Ribosome profiling upon inhibition of eIF4A 1.34
Uridylation by TUT4 and TUT7 marks mRNA for degradation [RNA-Seq] 1.32
Regulatory network controlling tumor-promoting inflammation in human cancers [RNA-seq] 1.27
Regulatory network controlling tumor-promoting inflammation in human cancers 1.27
ATF7IP-mediated stabilization of the histone methyltransferase SETDB1 is essential for heterochromatin formation by the HUSH complex 1.25
Assessing the impact of loss of ATF7IP and SETDB1 on the transcriptome 1.25
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.19
Identification of long noncoding RNAs in T-ALL cell lines 1.13
Transcriptome profiling of A2M treated A549 Cell Line Samples 1.09
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 1.0
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 0.98
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 0.98
Comparing oestrogen-responsive genes in endometrial and breast cancer cell lines 0.95
Genome-wide expression from the esophageal biopsies of subjects with and without eosinophilic esophagitis 0.92
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.84
Mutually Exclusive CBC-Containing Complexes Contribute to RNA Fate. 0.82
UV-Irradiation Induces a Noncoding RNA that Functionally Opposes the Protein Encoded by the Same Gene 0.79
Xeno-free and Chemically Defined Human System for Culturing Human Epidermal Keratinocytes 0.77
mRNA expression levels in splenic human mononuclear cells of mock- and HIV-1-infected humanized mice 0.73
Mesothelioma xenografts in nude mice: PBS treated versus pirfenidone treated 0.71
TimeLapse-seq: adding a temporal dimension to RNA sequencing through nucleoside recoding 0.67
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program 0.67
RUNX1 mutations lead to a myeloid differentiation block by altering the RUNX1 transcriptional program (RNA-Seq) 0.67
RNA expression profiles comparing primary and omental ovarian carcinoma samples 0.66
RNA-Seq of SHEP TET21N cells upon Doxorubicin treatment 0.64
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease 0.61
Pre-clinical evaluation of cysteamine bitartrate as a therapeutic agent for mitochondrial respiratory chain disease (human) 0.61
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.59
Myc activation coordinates gene transcription and protein translation responses 0.56
Targeting Spt5-Pol II small-molecule inhibitors uncouple distinct activities and reveal additional regulatory roles 0.54
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.52
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.5
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing Mbnl1 [RNA-seq & Ribo-seq] 0.48
The RNA hairpin binder TRIM71 modulates alternative splicing by repressing MBNL1 0.48
CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia 0.46
MHC Transcriptomic landscape at haplotype-specific resolution 0.46
Splicing function of mitotic regulators links R-loop mediated DNA damage to tumor cell killing 0.38
Acetylation-Dependent Control of Global Poly(A) RNA Degradation by CBP/p300 and HDAC1/2 0.36
Transcriptome-profiling (RNA-seq) and Ribosome-profiling (Ribo-seq) in proliferation, quiescence, senescence and transformed states. 0.25
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation 0.24
Inheritable Silencing of Endogenous Genes by Hit-and-Run Targeted Epigenetic Editing 0.2
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.19
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.19
The effect of slow and rapid H2S production on the levels of LPS-induced proinflammatory mediators and transcription in different human cell cultures 0.14
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.11
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.11
Expression profile of MM.1S tumors folloiwing treatment with bortezomib 0.1
Mouse Dux is myotoxic and shares partial functional homology with its human paralog DUX4 0.1


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation